Abstract
Introduction: Chronic kidney disease (CKD) affects people across their lifespan. Kidney supportive care (KSC) is typically offered for older people for symptom management, education, and/or advance care planning (ACP). However, younger people may also benefit from KSC. This study sought to explore characteristics of working-age adults with CKD accessing KSC. Methods: Using a cross-sectional design, working-age adults (18–64 years) with CKD referred to a KSC service from February 2016 to July 2021 were included. Demographic and clinical data were extracted from patients’ hospital records. Self-reported symptoms (Integrated Palliative Care Outcome Scale renal [IPOS-renal]) and health-related quality of life (European quality of life [EQ-5D-5L]) were assessed. Reasons for referral to KSC, kidney replacement therapy (KRT) pathway at referral, and comorbidity calculated using the Charlson Comorbidity Index were also assessed. Results: One Hundred Fifty-six working-age adults attended the KSC service. Median age was 57 years, with more than half receiving KRT. Weakness (92.2%), poor mobility (83.3%), and pain (82.5%) were the most prevalent and severe symptoms. The majority were referred for symptom management (n = 83, 53.2%) and 27% for ACP (n = 42). The ACP completion rate was low (28.9%). Those on dialysis had significantly higher symptom scores than those not receiving dialysis (p < 0.05). Conclusion: Working-age adults with CKD experience a significant and debilitating symptom burden and need to consider options for treatment. This study provides new understanding about working-age adults with CKD that may help provide the specific support needed to meet their end-of-life care needs.
Journal Section:
Clinical Practice: Research Article
References
1.
Kalantar-Zadeh
K
, Jafar
TH
, Nitsch
D
, Neuen
BL
, Perkovic
V
. Chronic kidney disease
. Lancet
. 2021
;398
(10302
):786
–802
.2.
Webster
AC
, Nagler
EV
, Morton
RL
, Masson
P
. Chronic kidney disease
. Lancet
. 2017
;389
(10075
):1238
–52
.3.
Charles
C
, Ferris
AH
. Chronic kidney disease
. Prim Care
. 2020
;47
(4
):585
–95
.4.
Yapa
H
, Purtell
L
, Chambers
S
, Bonner
A
. The relationship between chronic kidney disease, symptoms and health-related quality of life: a systematic review
. J Ren Care
. 2020
;46
(2
):74
–84
.5.
Almutary
H
, Bonner
A
, Douglas
C
. Symptom burden in chronic kidney disease: a review of recent literature
. J Ren Care
. 2013
;39
(3
):140
–50
.6.
Murtagh
FE
, Addington-Hall
J
, Higginson
IJ
. The prevalence of symptoms in end-stage renal disease: a systematic review
. Adv Chronic Kidney Dis
. 2007
;14
(1
):82
–99
.7.
Davison
SN
, Levin
A
, Moss
AH
, Jha
V
, Brown
EA
, Brennan
F
. Executive summary of the kdigo controversies conference on supportive care in chronic kidney disease: developing a roadmap to improving quality care
. Kidney Int
. 2015
;88
(3
):447
–59
.8.
9.
10.
Adams
ML
. Differences between younger and older US adults with multiple chronic conditions
. Prev Chronic Dis
. 2017
14
E76
.11.
Salsman
JM
, Garcia
SF
, Yanez
B
, Sanford
SD
, Snyder
MA
, Victorson
D
. Physical, emotional, and social health differences between posttreatment young adults with cancer and matched healthy controls
. Cancer
. 2014
;120
(15
):2247
–54
.12.
Stone
D
, Ganz
P
, Pavlish
C
, Robbins
W
, Stone
DS
, Ganz
PA
. Young adult cancer survivors and work: a systematic review
. J Cancer Surviv
. 2017
;11
(6
):765
–81
.13.
Zebrack
BJ
. Psychological, social, and behavioral issues for young adults with cancer
. Cancer
. 2011
117
10 Suppl
2289
94
.14.
Krischock
L
, Kennedy
SE
, Hayen
A
. Multicentre study of treatment outcomes in Australian adolescents and young adults commencing dialysis
. Nephrology
. 2017
;22
(12
):961
–8
.15.
Murray
PD
, Dobbels
F
, Lonsdale
DC
, Harden
PN
. Impact of end-stage kidney disease on academic achievement and employment in young adults: a mixed methods study
. J Adolesc Health
. 2014
;55
(4
):505
–12
.16.
Murray
PD
, Brodermann
MH
, Gralla
J
, Wiseman
AC
, Harden
PN
. Academic achievement and employment in young adults with end-stage kidney disease
. J Ren Care
. 2019
;45
(1
):29
–40
.17.
Reid
C
, Seymour
J
, Jones
C
. A thematic synthesis of the experiences of adults living with hemodialysis
. Clin J Am Soc Nephrol
. 2016
;11
(7
):1206
–18
.18.
Mok
M
, Liu
C
, Lam
MF
, Kwan
L
, Chan
G
, Ma
M
. A longitudinal study on the prevalence and risk factors for depression and anxiety, quality of life, and clinical outcomes in incident peritoneal dialysis patients
. Perit Dial Int
. 2019
;39
(1
):74
–82
.19.
Von Elm
E
, Altman
DG
, Egger
M
, Pocock
SJ
, Gotzsche
PC
, Vandenbroucke
JP
STROBE Initiative
. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies
. Ann Intern Med
. 2007
;147
(8
):573
–7
.20.
Cicely Saunders Institute. Palliative care outcome scale: IPOS-Renal [cited 2021 Nov 1]. Available from: https://pos-pal.org/maix/ipos-renal-in-english.php.
21.
EuroQol. EQ-5D-5L samples/demos [cited 2021 Nov 1]. Available from: https://euroqol.org/eq-5d-instruments/sample-demo/.
22.
Charlson
M
. Charlson comorbidity index. MDCALC [cited 2021 Nov 1]. Available from: https://www.mdcalc.com/charlson-comorbidity-ubdex-cci.23.
Australian Institute of Health and Welfare
. Resource utilisation groups activities of daily living [cited 2021 Nov 1]. Available from: https://meteor.aihw.gov.au/content/index.phtml/itemId/495909.24.
Abernethy
AP
, Shelby-James
T
, Fazekas
BS
, Woods
D
, Currow
DC
. The Australia-modified Karnofsky performance status (AKPS) scale: a revised scale for contemporary palliative care clinical practice
. BMC Palliat Care
. 2005
;4
(1
):1
–12
.25.
IBM SPSS TM statistics for Windows. Version 27.0
Armonk, NY
IBM Corp
2015
.26.
27.
Li
H
, Xie
L
, Yang
J
, Pang
X
. Symptom burden amongst patients suffering from end-stage renal disease and receiving dialysis: a literature review
. Int J Nurs Sci
. 2018
;5
(4
):427
–31
.28.
Brown
SA
, Tyrer
FC
, Clarke
AL
, Lloyd-Davies
LH
, Stein
AG
, Tarrant
C
. Symptom burden in patients with chronic kidney disease not requiring renal replacement therapy
. Clin Kidney J
. 2017
;10
(6
):788
–96
.29.
Senanayake
S
, Gunawardena
N
, Palihawadana
P
, Bandara
P
, Haniffa
R
, Karunarathna
R
. Symptom burden in chronic kidney disease: a population based cross sectional study
. BMC Nephrol
. 2017
;18
(1
):228
.30.
Yapa
HE
, Purtell
L
, Chambers
S
, Bonner
A
. Alterations in symptoms and health-related quality of life as kidney function deteriorates: a cross-sectional study
. J Clin Nurs
. 2021
30
11–12
1787
96
.31.
Moskovitch
JT
, Mount
PF
, Davies
MR
. Changes in symptom burden in dialysis patients assessed using a symptom-reporting questionnaire in clinic
. J Palliat Care
. 2020
;35
(1
):59
–65
.32.
Artom
M
, Moss-Morris
R
, Caskey
F
, Chilcot
J
. Fatigue in advanced kidney disease
. Kidney Int
. 2014
;86
(3
):497
–505
.33.
Nowe
E
, Friedrich
M
, Leuteritz
K
, Sender
A
, Stöbel-Richter
Y
, Schulte
T
. Cancer-related fatigue and associated factors in young adult cancer patients
. J Adolesc Young Adult Oncol
. 2019
;8
(3
):297
–303
.34.
Corey
AL
, Haase
JE
, Azzouz
F
, Monahan
PO
. Social support and symptom distress in adolescents/young adults with cancer
. J Pediatr Oncol Nurs
. 2008
;25
(5
):275
–84
.35.
Murnane
A
, Kiss
N
, Fraser
SF
, Lewin
J
. Health-related quality of life, fatigue and health behaviours in Australian adolescent and young adult cancer survivors
. Pediatr Blood Cancer
. 2021
;68
(10
):e29243
.36.
Nixon
AC
, Wilkinson
TJ
, Young
H
, Taal
MW
, Pendleton
N
, Mitra
S
. Symptom-burden in people living with frailty and chronic kidney disease
. BMC Nephrol
. 2020
;21
(1
):411
.37.
Ren
Q
, Shi
Q
, Ma
T
, Wang
J
, Li
Q
, Li
X
. Quality of life, symptoms, and sleep quality of elderly with end-stage renal disease receiving conservative management: a systematic review
. Health Qual Life Outcomes
. 2019
;17
(1
):78
.38.
Purtell
L
, Sowa
PM
, Berquier
I
, Scuderi
C
, Douglas
C
, Taylor
B
. The kidney supportive care programme: characteristics of patients referred to a new model of care
. BMJ Support Palliat Care
. 2018
; bmjspcare-2018-001630. 39.
Huang
CW
, Wee
PH
, Low
LL
, Koong
YL
, Htay
H
, Fan
Q
. Prevalence and risk factors for elevated anxiety symptoms and anxiety disorders in chronic kidney disease: a systematic review and meta-analysis
. Gen Hosp Psychiatry
. 2021
;69
:27
–40
.40.
Song
M
, Ward
SE
, Hladik
GA
, Bridgman
JC
, Gilet
CA
. Depressive symptom severity, contributing factors, and self-management among chronic dialysis patients
. Hemodial Int
. 2016
;20
(2
):286
–92
.41.
Pereira
B
, Fernandes
N
, De Melo
NP
, Abrita
R
, Grincenkov
FR
, Fernandes
N
. Beyond quality of life: a cross sectional study on the mental health of patients with chronic kidney disease undergoing dialysis and their caregivers
. Health Qual Life Outcomes
. 2017
;15
(1
):74
.42.
Jung
H
, Tanaka
S
, Iwamoto
Y
, Yamasaki
M
, Tanaka
R
. Relationship between mobility-related activities of daily living and health-related quality of life among healthy older adults: a cross-sectional study using structural equation modeling
. Gerontol Geriatr Med
. 2021
;7
:23337214211013166
.43.
Hordon
L
. Limited joint mobility and other musculoskeletal problems in diabetes
. Diabetes Prim Care
. 2017
;19
(1
):29
–34
.44.
Junqué Jiménez
A
, Esteve Simó
V
, Andreu Periz
L
, Segura Ortí
E
. The relationship between physical activity levels and functional capacity in patients with advanced chronic kidney disease
. Clin Nurs Res
. 2021
;30
(3
):360
–8
.45.
Tsai
Y
, Chen
H
, Hsiao
S
, Chen
C
, Lin
M
, Chiu
Y
. Association of physical activity with cardiovascular and renal outcomes and quality of life in chronic kidney disease
. PLoS One
. 2017
;12
(8
):e0183642
.46.
Artzi-Medvedic
R
, Kob
R
, Fabbietti
P
, Lattanzio
F
, Corsonello
A
, Corsonello
A
. Impaired kidney function is associated with lower quality of life among community-dwelling older adults
. BMC Geriatr
. 2020
;20
(1
):1
–10
.47.
Oskoui
T
, Pandya
R
, Weiner
DE
, Wong
JB
, Koch-Weser
S
, Ladin
K
. Advance care planning among older adults with advanced non–dialysis-dependent CKD and their care partners: perceptions versus reality
. Kidney Med
. 2020
;2
(2
):116
–24
.48.
Saeed
F
, Sardar
MA
, Davison
SN
, Murad
H
, Duberstein
PR
, Quill
TE
. Patients’ perspectives on dialysis decision-making and end-of-life care
. Clin Nephrol
. 2019
;91
(5
):294
–300
.49.
Wachterman
MW
, Lipsitz
SR
, Lorenz
KA
, Marcantonio
ER
, Li
Z
, Keating
NL
. End-of-life experience of older adults dying of end-stage renal disease: a comparison with cancer
. J Pain Symptom Manage
. 2017
;54
(6
):789
–97
.50.
Bernacki
GM
, McDermott
CL
, Matlock
DD
, O'Hare
AM
, Brumback
L
, Bansal
N
. Advance care planning documentation and intensity of care at the end of life for adults with congestive heart failure, chronic kidney disease, and both illnesses
. J Pain Symptom Manage
. 2022 Feb
63
2
e168
175
.51.
Ducharlet
K
, Philip
J
, Kiburg
K
, Gock
H
. Renal supportive care, palliative care and end-of-life care: perceptions of similarities, differences and challenges across Australia and New Zealand
. Nephrology
. 2021
;26
(1
):15
–22
.52.
Kermel-Schiffman
I
, Werner
P
. Knowledge regarding advance care planning: a systematic review
. Arch Gerontol Geriatr
. 2017
;73
:133
–42
.53.
Hole
B
, Hemmelgarn
B
, Brown
E
, Brown
M
, McCulloch
MI
, Zuniga
C
. Supportive care for end-stage kidney disease: an integral part of kidney services across a range of income settings around the world
. Kidney Int Suppl
. 2020
;10
(1
):e86
–e94
.54.
Murtagh
FEM
, Burns
A
, Moranne
O
, Morton
RL
, Naicker
S
. Supportive care: comprehensive conservative care in end-stage kidney disease
. Clin J Am Soc Nephrol
. 2016
;11
(10
):1909
–14
.© 2023 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2023
You do not currently have access to this content.
